IP Library Granted Patent US 6,908,741
Granted Patent B1
US 6,908,741 · App. 09/799,152 · Granted Jun 21, 2005

Methods to identify compounds that modulate RAGE

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,908,741
App. No.
09/799,152
Granted
Jun 21, 2005
Kind
B1
Abstract

Provided are methods to detect of modulators of the Receptor for Advanced Glycated Endproducts (RAGE). The invention comprises a method for detection of RAGE modulators comprising: adsorbing a RAGE ligand onto a solid surface; adding a compound of interest and a protein comprising RAGE or fragment thereof, to the preadsorbed ligand; adding an antibody which binds to RAGE or fragment thereof and a secondary antibody which binds to the anti-RAGE antibody; measuring the secondary antibody bound to the anti-RAGE antibody; and comparing the amount of RAGE bound to the ligand in the presence of varying amounts of the compound of interest. In an embodiment, the fragment of RAGE is sRAGE. In one aspect, the invention use of compounds detected by the method for treatment of AGE-related syndromes including complications associated with diabetes, kidney failure, lupus nephritis or inflammatory lupus nephritis, amyloidoses, Alzheimer's disease, cancer, inflammation, and erectile dysfunction.

Claims (31)

1. A method for detection of RAGE ligands comprising:

adsorbing a RAGE ligand onto a solid surface;

adding a compound of interest and a protein comprising sRAGE as defined by the amino acid sequence SEQ ID NO: 2, to the preadsorbed ligand;

adding anti-RAGE antibody which binds to the sRAGE protein;

determining the amount of sRAGE protein bound to the ligand by measuring the amount of anti-RAGE antibody bound; and

comparing the amount of sRAGE protein bound to the ligand in the presence of varying amounts of the compound of interest.

2. The method of claim 1 , wherein the anti-RAGE antibody comprises a monoclonal antibody.

3. The method of claim 1 , herein the anti-RAGE antibody comprises a polyclonal antibody.

4. The method of claim 1 , further comprising adding a second antibody which recognizes the anti-RAGE antibody.

5. The method of claim 4 , wherein the anti-RAGE antibody and secondary antibody are allowed to complex prior to being added.

6. The method of claim 4 , further comprising performing a calorimetric assay for the secondary antibody.

7. The method of claim 1 , wherein the solid surface comprises a microtiter well.

8. The method of claim 1 , wherein the solid surface comprises a dip-stick.

9. The method of claim 1 , wherein the ligand comprises S100b.

10. The method of claim 1 , wherein the compound of interest comprises a synthetic peptide.

11. The method of claim 1 , wherein the compound of interest comprises a peptidomimetic.

12. The method of claim 1 , wherein the compound of interest comprises an organic compound.

13. The method of claim 1 , wherein the compound of interest comprises an inorganic compound.

14. The method of claim 1 , wherein the compound of interest comprises a lipid.

15. The method of claim 1 , wherein the compound of interest comprises a carbohydrate.

16. The method of claim 1 , wherein compound of interest comprises a nucleic acid.

17. A method for detection of RAGE ligands comprising:

adsorbing a RAGE ligand onto a solid surface;

adding a compound of interest and a protein comprising RAGE as defined by the amino acid sequence SEQ ID NO: 2 to the preabsorbed ligand;

adding anti-RAGE antibody which binds to the sRAGE protein and a secondary antibody which binds to the anti-RAGE antibody;

measuring the secondary antibody bound to the anti-RAGE antibody; and

comparing the amount of sRAGE protein bound to the ligand in the presence of varying amounts of the compound of interest.

18. The method of claim 17 , further comprising performing a calorimetric assay for the secondary antibody.

19. The method of claim 17 , wherein the anti-RAGE antibody and secondary antibody are allowed to complex prior to being added to the reaction.

20. The method of claims 17 , wherein the solid surface comprises a reaction vessel.

21. The method of claim 17 , wherein the solid surface comprises a dip-stick.

Assignments (10)
CORRECTIVE ASSIGNMENT TO CORRECT THE RECEIVING PARTY DATA PREVIOUSLY RECORDED AT REEL: 036254 FRAME: 0780. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Sep 24, 2015
From: M&F TTP HOLDINGS LLC, AS COLLATERAL AGENT
To: VTVX HOLDINGS I LLC
Reel/Frame 036675/0407 →
RELEASE OF SECURITY INTEREST Recorded Aug 3, 2015
From: M&F TTP HOLDINGS LLC, AS COLLATERAL AGENT
To: VTVX HOLDINGS II LLC
Reel/Frame 036254/0780 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 31, 2015
From: VTVX HOLDINGS I LLC
To: VTV THERAPEUTICS LLC
Reel/Frame 036242/0354 →
CHANGE OF NAME Recorded Jul 30, 2015
From: VTV THERAPEUTICS LLC
To: VTVX HOLDINGS I LLC
Reel/Frame 036236/0165 →
CHANGE OF NAME Recorded Jun 25, 2015
From: TRANSTECH PHARMA, LLC
To: VTV THERAPEUTICS LLC
Reel/Frame 036026/0219 →
SECURITY INTEREST Recorded Feb 26, 2015
From: TRANSTECH PHARMA, LLC
To: M&F TTP HOLDINGS LLC, AS COLLATERAL AGENT
Reel/Frame 035103/0356 →
NOTICE OF RELEASE OF SECURITY INTEREST IN PATENTS FOR REEL/FRAME 030982/0803 Recorded Apr 7, 2014
From: M&F TTP HOLDINGS LLC
To: TRANSTECH PHARMA, LLC
Reel/Frame 032621/0860 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 22, 2013
From: TRANSTECH PHARMA, INC.
To: TRANSTECH PHARMA, LLC
Reel/Frame 031654/0878 →
SECURITY AGREEMENT Recorded Aug 9, 2013
From: TRANSTECH PHARMA, INC.
To: M&F TTP HOLDINGS LLC C/O MACANDREWS & FORBES HOLDINGS INC.
Reel/Frame 030982/0803 →
CONFIRMATION OF TERMINATION OF EXCLUSIVE PATENT LICENSE Recorded Jan 15, 2013
From: PFIZER, INC.
To: TRANSTECH PHARMA, INC.
Reel/Frame 029631/0111 →